Zerong Cai

718 total citations
22 papers, 465 citations indexed

About

Zerong Cai is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Zerong Cai has authored 22 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Oncology, 8 papers in Surgery and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Zerong Cai's work include Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers) and Genetic factors in colorectal cancer (4 papers). Zerong Cai is often cited by papers focused on Colorectal Cancer Treatments and Studies (5 papers), Colorectal Cancer Surgical Treatments (5 papers) and Genetic factors in colorectal cancer (4 papers). Zerong Cai collaborates with scholars based in China, United States and Hong Kong. Zerong Cai's co-authors include Chuchu Zhang, Sara L. Prescott, Yandan Wang, Stephen D. Liberles, Judith A. Kaye, Xiaojian Wu, Ping Lan, Yufeng Chen, Yifeng Zou and Xiaosheng He and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Neuron and Journal of Clinical Oncology.

In The Last Decade

Zerong Cai

20 papers receiving 459 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zerong Cai China 10 148 134 80 77 60 22 465
Elias Q. Scherer Germany 14 172 1.2× 105 0.8× 113 1.4× 98 1.3× 39 0.7× 19 606
Chengshi Xu China 15 224 1.5× 59 0.4× 71 0.9× 49 0.6× 38 0.6× 35 617
Toru Nanmoku Japan 16 189 1.3× 70 0.5× 69 0.9× 61 0.8× 12 0.2× 37 578
Megumu Tanaka Japan 15 213 1.4× 67 0.5× 40 0.5× 49 0.6× 44 0.7× 27 454
Jack Ham United Kingdom 11 190 1.3× 72 0.5× 53 0.7× 35 0.5× 14 0.2× 22 519
Hisaka Kawate Japan 17 360 2.4× 106 0.8× 69 0.9× 74 1.0× 54 0.9× 33 702
Yuka Ichikawa‐Shindo Japan 17 330 2.2× 106 0.8× 70 0.9× 75 1.0× 54 0.9× 31 675
Ayami Kondo Japan 12 230 1.6× 87 0.6× 36 0.5× 89 1.2× 20 0.3× 20 468
Jun‐Ge Yu United States 12 142 1.0× 53 0.4× 54 0.7× 127 1.6× 20 0.3× 17 495
Mina Elahy Australia 11 156 1.1× 46 0.3× 38 0.5× 105 1.4× 16 0.3× 15 487

Countries citing papers authored by Zerong Cai

Since Specialization
Citations

This map shows the geographic impact of Zerong Cai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zerong Cai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zerong Cai more than expected).

Fields of papers citing papers by Zerong Cai

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zerong Cai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zerong Cai. The network helps show where Zerong Cai may publish in the future.

Co-authorship network of co-authors of Zerong Cai

This figure shows the co-authorship network connecting the top 25 collaborators of Zerong Cai. A scholar is included among the top collaborators of Zerong Cai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zerong Cai. Zerong Cai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Hoagland, Adam, et al.. (2025). Behavioral resilience via dynamic circuit firing homeostasis. Proceedings of the National Academy of Sciences. 122(18). e2421386122–e2421386122. 2 indexed citations
3.
Cai, Zerong, Di Chen, Haojie Chen, et al.. (2024). Diagnosis and prognosis prediction of gastric cancer by high-performance serum lipidome fingerprints. EMBO Molecular Medicine. 16(12). 3089–3112. 5 indexed citations
4.
Hu, Chuling, Zhaoliang Yu, Xinxin Huang, et al.. (2024). KRAS inhibitors may prevent colorectal cancer metachronous metastasis by suppressing TGF‑β mediated epithelial‑mesenchymal transition. Molecular Medicine Reports. 31(1). 2 indexed citations
5.
You, Weiqiang, et al.. (2022). Comprehensive Analyses of Immune Subtypes of Stomach Adenocarcinoma for mRNA Vaccination. Frontiers in Immunology. 13. 827506–827506. 13 indexed citations
6.
You, Weiqiang, Zerong Cai, Nengquan Sheng, et al.. (2022). Construction and Validation of Convenient Clinicopathologic Signatures for Predicting the Prognosis of Stage I-III Gastric Cancer. Frontiers in Oncology. 12. 848783–848783. 2 indexed citations
7.
Harbauer, Angelika B., Simone Wanderoy, Inmaculada Segura, et al.. (2022). Neuronal mitochondria transport Pink1 mRNA via synaptojanin 2 to support local mitophagy. Neuron. 110(9). 1516–1531.e9. 90 indexed citations
8.
Chen, Yufeng, Zhaoliang Yu, Zerong Cai, et al.. (2021). Cancer-associated fibroblasts impact the clinical outcome and treatment response in colorectal cancer via immune system modulation: a comprehensive genome-wide analysis. Molecular Medicine. 27(1). 139–139. 22 indexed citations
9.
Zhang, Chuchu, Judith A. Kaye, Zerong Cai, et al.. (2020). Area Postrema Cell Types that Mediate Nausea-Associated Behaviors. Neuron. 109(3). 461–472.e5. 163 indexed citations
10.
Ke, Jia, Xiaofeng Jiang, Zhen He, et al.. (2020). Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients. European Journal of Surgical Oncology. 46(10). e62–e70. 8 indexed citations
11.
You, Weiqiang, Yan Li, Zerong Cai, et al.. (2020). Clinical Significances of Positive Postoperative Serum CEA and Post-preoperative CEA Increment in Stage II and III Colorectal Cancer: A Multicenter Retrospective Study. Frontiers in Oncology. 10. 671–671. 28 indexed citations
12.
Cai, Zerong, Yufeng Chen, Xiaoyu Xie, et al.. (2020). CEA Decline Predicts Tumor Regression and Prognosis in Locally Advanced Rectal Cancer Patients with Elevated Baseline CEA. Journal of Cancer. 11(22). 6565–6570. 9 indexed citations
13.
Ke, Jia, Xuanhui Liu, Xiaofeng Jiang, et al.. (2019). Immune-related gene signature in predicting prognosis of early-stage colorectal cancer patients.. Journal of Clinical Oncology. 37(15_suppl). 3586–3586. 1 indexed citations
14.
Cai, Zerong, Jian Xiao, Xiaosheng He, et al.. (2017). Accessing new prognostic significance of preoperative carcinoembryonic antigen in colorectal cancer receiving tumor resection: More than positive and negative. Cancer Biomarkers. 19(2). 161–168. 8 indexed citations
15.
Lin, Xutao, Dejun Fan, Zerong Cai, et al.. (2016). Similar outcomes for anti-tumor necrosis factor-α antibody and immunosuppressant following seton drainage in patients with Crohn's disease-related anal fistula. Experimental and Therapeutic Medicine. 12(3). 1939–1945. 3 indexed citations
17.
He, Zhen, Xiaosheng He, Jia Ke, et al.. (2014). Activation of the mTORC1 and STAT3 pathways promotes the malignant transformation of colitis in mice. Oncology Reports. 32(5). 1873–1880. 26 indexed citations
18.
Li, Gang, Yufeng Chen, Zerong Cai, et al.. (2013). 5-Fluorouracil-loaded poly-l-lactide fibrous membrane for the prevention of intestinal stent restenosis. Journal of Materials Science. 48(18). 6186–6193. 15 indexed citations
19.
Zou, Yifeng, Yufeng Chen, Xianrui Wu, et al.. (2013). CCL21 as an independent favorable prognostic factor for stage III/IV colorectal cancer. Oncology Reports. 30(2). 659–666. 16 indexed citations
20.
Chen, Yufeng, Xiaosheng He, Xianrui Wu, et al.. (2013). CCL18 as an independent favorable prognostic biomarker in patients with colorectal cancer. Journal of Surgical Research. 183(1). 163–169. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026